We are live on
!
Find out more
Commonwealth Equity Services Portfolio holdings
AUM
$79.5B
1-Year Est. Return
27.1%
This Fund
S&P 500
This Quarter
Est. Return
+15.68%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.22%
AUM
$79.5B
AUM Growth
+$7.93B
(+11%)
Cap. Flow
-$643M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
16.98%
Holding
4,611
New
312
Increased
1,846
Reduced
2,170
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$70M |
| 2 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$65.3M |
| 3 |
Fidelity Fundamental Large Cap Growth ETF
FFLG
|
+$50M |
| 4 |
Eli Lilly
LLY
|
+$42.5M |
| 5 |
SPCX
SpaceX
SPCX
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$122M |
| 2 |
NVIDIA
NVDA
|
+$99.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.3M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$79.7M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$69.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.62% |
| 2 | Technology | 12.02% |
| 3 | Financials | 4.01% |
| 4 | Industrials | 3.47% |
| 5 | Consumer Discretionary | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
CEL-SCI Corp
CVM
$28.7M
| $53.5K | ﹤0.01% |
51,434
+33,812
| +192% | +$74.1K |
|
4302
Broadwind
BWEN
$98.2M
| $53.1K | ﹤0.01% |
+10,994
| New | +$36.4K |
|
4303
Incannex Healthcare
IXHL
$38.9M
| $52.8K | ﹤0.01% |
14,029
+1,917
| +16% | +$7K |
|
|
CMRC
4304
Commerce.com Inc Series 1
CMRC
$213M
| $52.3K | ﹤0.01% |
17,661
| – | – |
|
4305
Bausch Health
BHC
$2.45B
| $52.2K | ﹤0.01% |
+10,592
| New | +$56.8K |
|
4306
B&G Foods
BGS
$267M
| $51.8K | ﹤0.01% |
13,020
-2,157
| -14% | -$10K |
|
4307
Lexeo Therapeutics
LXEO
$401M
| $51.8K | ﹤0.01% |
11,123
-2,497
| -18% | -$13.5K |
|
4308
MIRA Pharmaceuticals
MIRA
$32.1M
| $50.3K | ﹤0.01% |
53,189
+18,122
| +52% | +$18.3K |
|
|
NEUP
4309
Neuphoria Therapeutics
NEUP
$20.4M
| $49K | ﹤0.01% |
11,222
| – | – |
|
4310
Sundial Growers
SNDL
$358M
| $46.4K | ﹤0.01% |
34,363
+273
| +0.8% | +$391 |
|
4311
W&T Offshore
WTI
$577M
| $45.9K | ﹤0.01% |
14,556
+3,656
| +34% | +$13.6K |
|
4312
Gevo
GEVO
$405M
| $45.4K | ﹤0.01% |
30,281
| – | – |
|
4313
Protalix BioTherapeutics
PLX
$215M
| $45.3K | ﹤0.01% |
19,461
| – | – |
|
4314
Microvast
MVST
$266M
| $43.2K | ﹤0.01% |
36,929
+23,000
| +165% | +$35.4K |
|
4315
Protara Therapeutics
TARA
$233M
| $42K | ﹤0.01% |
11,000
| – | – |
|
|
ESPR
4316
DELISTED
Esperion Therapeutics
ESPR
| $41.2K | ﹤0.01% |
13,050
-8,000
| -38% | -$22.4K |
|
4317
Voyager Therapeutics
VYGR
$216M
| $41K | ﹤0.01% |
11,704
+400
| +4% | +$1.52K |
|
4318
Genelux
GNLX
$110M
| $39.4K | ﹤0.01% |
13,083
-4,000
| -23% | -$11.3K |
|
4319
ALX Oncology
ALXO
$278M
| $38.2K | ﹤0.01% |
+18,451
| New | +$33K |
|
|
PNNT
4320
Pennant Park Investment Corp
PNNT
$244M
| $37.7K | ﹤0.01% |
10,863
-36,224
| -77% | -$150K |
|
|
ONL
4321
Orion Office REIT
ONL
$155M
| $36.5K | ﹤0.01% |
12,618
-1,476
| -10% | -$4.04K |
|
4322
Richtech Robotics
RR
$394M
| $36.3K | ﹤0.01% |
17,182
-14,175
| -45% | -$34.4K |
|
|
ABTC
4323
American Bitcoin Corp
ABTC
$582M
| $35.7K | ﹤0.01% |
3,497
+106
| +3% | +$1.62K |
|
4324
AEye
LIDR
$63.7M
| $34.3K | ﹤0.01% |
+23,811
| New | +$43K |
|
|
ONCY
4325
Oncolytics Biotech
ONCY
$108M
| $33.4K | ﹤0.01% |
35,114
| – | – |
|
Similar funds
BC
Commonwealth Equity Services's Q2 2026 Portfolio in Review
As of Q2 2026, Commonwealth Equity Services held 4,611 positions worth $79.5B, up 11% from $71.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Commonwealth Equity Services's Q2 2026 filing shows 312 new, 1,846 increased, 2,170 reduced and 196 closed positions. Its largest new stake was SpaceX: 238,120 shares worth $40.7M. The largest sale was Apple, an estimated $122M.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, up from 66% a quarter earlier, followed by Technology and Financials.
- Commonwealth Equity Services's largest Q2 2026 buy was SpaceX: 238,120 shares worth $40.7M.
- Commonwealth Equity Services added most to Invesco NASDAQ 100 ETF in Q2 2026, an estimated $70M increase.
- Commonwealth Equity Services's biggest Q2 2026 reduction was Apple, cutting an estimated $122M.
- Commonwealth Equity Services fully exited Convergence Long/Short Equity ETF in Q2 2026, selling an estimated $7.88M.
- Commonwealth Equity Services's ten largest holdings make up 17% of its $79.5B portfolio in Q2 2026.
- Commonwealth Equity Services opened 312 new positions and closed 196 in Q2 2026.
- Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $79.5B.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.